4z8e: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==TEAD DBD mutant -deltaL1== | ==TEAD DBD mutant -deltaL1== | ||
<StructureSection load='4z8e' size='340' side='right' caption='[[4z8e]], [[Resolution|resolution]] 2.09Å' scene=''> | <StructureSection load='4z8e' size='340' side='right'caption='[[4z8e]], [[Resolution|resolution]] 2.09Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4z8e]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4Z8E OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4Z8E FirstGlance]. <br> | <table><tr><td colspan='2'>[[4z8e]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4Z8E OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4Z8E FirstGlance]. <br> | ||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4z8e FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4z8e OCA], [http://pdbe.org/4z8e PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4z8e RCSB], [http://www.ebi.ac.uk/pdbsum/4z8e PDBsum]</span></td></tr> | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">TEAD1, TCF13, TEF1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4z8e FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4z8e OCA], [http://pdbe.org/4z8e PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4z8e RCSB], [http://www.ebi.ac.uk/pdbsum/4z8e PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4z8e ProSAT]</span></td></tr> | |||
</table> | </table> | ||
== Disease == | == Disease == | ||
Line 23: | Line 24: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | |||
[[Category: Large Structures]] | |||
[[Category: Albarado, D C]] | [[Category: Albarado, D C]] | ||
[[Category: Lee, D S]] | [[Category: Lee, D S]] |
Revision as of 10:11, 19 June 2019
TEAD DBD mutant -deltaL1TEAD DBD mutant -deltaL1
Structural highlights
Disease[TEAD1_HUMAN] Defects in TEAD1 are the cause of Sveinsson chorioretinal atrophy (SCRA) [MIM:108985]; also known as atrophia areata (AA) or helicoidal peripapillary chorioretinal degeneration (HPCD). SCRA is characterized by symmetrical lesions radiating from the optic disk involving the retina and the choroid.[1] [2] [3] Function[TEAD1_HUMAN] Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expression of YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and epithelial mesenchymal transition (EMT) induction. Binds specifically and cooperatively to the SPH and GT-IIC 'enhansons' (5'-GTGGAATGT-3') and activates transcription in vivo in a cell-specific manner. The activation function appears to be mediated by a limiting cell-specific transcriptional intermediary factor (TIF). Involved in cardiac development. Binds to the M-CAT motif.[4] [5] Publication Abstract from PubMedTEA domain (TEAD) transcription factors are essential for the normal development of eukaryotes and are the downstream effectors of the Hippo tumor suppressor pathway. Whereas our earlier work established the three-dimensional structure of the highly conserved DNA-binding domain using solution NMR spectroscopy, the structural basis for regulating the DNA-binding activity remains unknown. Here, we present the X-ray crystallographic structure and activity of a TEAD mutant containing a truncated L1 loop, DeltaL1 TEAD DBD. Unexpectedly, the three-dimensional structure of the DeltaL1 TEAD DBD reveals a helix-swapped homodimer wherein helix 1 is swapped between monomers. Furthermore, each three-helix bundle in the domain-swapped dimer is a structural homolog of MYB-like domains. Our investigations of the DNA-binding activity reveal that although the formation of the three-helix bundle by the DeltaL1 TEAD DBD is sufficient for binding to an isolated M-CAT-like DNA element, multimeric forms are deficient for cooperative binding to tandemly duplicated elements, indicating that the L1 loop contributes to the DNA-binding activity of TEAD. These results suggest that switching between monomeric and domain-swapped forms may regulate DNA selectivity of TEAD proteins. A Potential Structural Switch for Regulating DNA-Binding by TEAD Transcription Factors.,Lee DS, Vonrhein C, Albarado D, Raman CS, Veeraraghavan S J Mol Biol. 2016 Mar 22. pii: S0022-2836(16)00194-7. doi:, 10.1016/j.jmb.2016.03.008. PMID:27016204[6] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
|
|